Register for Longitudinal Recording of Brain Function

May 1, 2024 updated by: Schwendner Maximilian, University Hospital Heidelberg

Register for Longitudinal Recording of Brain Function in Patients With Brain Diseases

The aim of this observational register study is to establish a registry that completely records and compiles the data from routinely performed technical examinations (navigated transcranial magnetic stimulation, intraoperative neuromonitoring and stimulation, MRI imaging including tractography and connectome) and clinical tests over time (pre-, intra- and postoperative, under adjuvant therapy, as part of follow-up care) of patients with intracranial masses and lesions.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with brain masses/lesions (especially tumors (cerebral and non-cerebral, inflammation (infectious and non-infectious), vascular pathologies)

Description

Inclusion Criteria:

  • Intracranial lesion
  • Age ≥ 18 years
  • Written consent to participate in the study

Exclusion Criteria:

  • Age < 18 years
  • Patients not able to give consent
  • Patients with intracranial ferromagnetic metal implants
  • Patients with implanted electronic devices

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive status
Time Frame: until last patient FU up to 48 months
Higher cognitive functions - determined by the Montreal Cognitive Assessment (MocA)
until last patient FU up to 48 months
Language status
Time Frame: until last patient FU up to 48 months
Language function tested by the Aphasia Check List
until last patient FU up to 48 months
Motor status
Time Frame: until last patient FU up to 48 months
Motor function according to the BMRC scale
until last patient FU up to 48 months
cortical data
Time Frame: until last patient FU up to 48 months
cortical nTMS-Data - distribution according the cortical parellation system
until last patient FU up to 48 months
Fiber tracts
Time Frame: until last patient FU up to 48 months
Volume of fiber tracts
until last patient FU up to 48 months
Fiber tracts
Time Frame: until last patient FU up to 48 months
fractional anisotropy of fiber tracts
until last patient FU up to 48 months
structural imaging (Connectome)
Time Frame: until last patient FU up to 48 months
characteristics of Connectome and Disconnectome analysis (Global Efficiency value)
until last patient FU up to 48 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

January 7, 2024

First Submitted That Met QC Criteria

May 1, 2024

First Posted (Actual)

May 6, 2024

Study Record Updates

Last Update Posted (Actual)

May 6, 2024

Last Update Submitted That Met QC Criteria

May 1, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Fun-Reg

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

For selected subgroups, data sharing is possible depending on data safety regulations

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients With Brain Masses/Lesions

Subscribe